(Unaudited data)

SALES IN THE THIRD QUARTER (VARIATION AT CURRENT EXCHANGE RATES)














In thousands of euros1st quarter2nd quarter3rd quarter
20232022Var.20232022Var.20232022Var.
France 54,580 77,055 -29.2% 52,277 54,283 -3.7% 56,005 58,275 -3.9%
Europe (excluding France) 39,220 34,476 +13.8% 23,656 26,228 -9.8% 30,561 35,744 -14.5%
North America 33,279 28,944 +15.0% 24,148 23,282 +3.7% 28,861 29,107 -0.8%
Other countries 5,220 5,305 -1.6% 7,504 7,189 +4.4% 5,683 5,295 +7.3%
Group total132,299145,780-9.2%107,585110,982-3.1%121,110128,422-5.7%

 

In thousands of euros1st quarter2nd quarter3rd quarter
20232022Var.20232022Var.20232022Var.
Non-proprietary homeopathic medicines 45,234 45,516 -0.6% 42,231 43,360 -2.6% 39,305 41,081 -4.3%
Homeopathic specialties 79,858 67,100 +19.0% 57,111 54,816 +4.2% 71,709 74,349 -3.6%
Other health products 7,206 33,164 -78.3% 8,243 12,806 -35.6% 10,096 12,992 -22.3%
Group total132,299145,780-9.2%107,585110,982-3.1%121,110128,422-5.7%

Sales in the third quarter of 2023 were down 5.7%. Adjusted for the decline in COVID test sales this comes to 2.8%, exclusively due to the drop-in exchange rates.

The 4.3% decline in non-proprietary homeopathic medicines is still mainly attributable to France.

Sales from homeopathic specialties fell 3.6%, due to lower sales of winter specialties following a warm September.

Sales of other healthcare products continued to decline, due to a decrease in COVID test sales in Europe, particularly in France.

This decline was partially offset by the launch of the CBD by Boiron® range in France, formulated using 98% natural-origin ingredients and comprising three products:

  • a cream gel that helps restore joint movement and comfort,
  • a gel (tube and roll-on) that helps to reduce tension and relax muscles.

CUMULATIVE SALES AS OF THE END OF SEPTEMBER 2023

In thousands of euros20232022Variation
at current
exchange rates		Variation
at constant
exchange rates
France 162,862 189,612 -14.1% -14.1%
Europe (excluding France) 93,437 96,448 -3.1% -0.8%
North America 86,287 81,334 +6.1% +8.6%
Other countries 18,407 17,789 +3.5% +3.9%
Group total360,994385,183-6.3%-5.2%

 

In thousands of euros20232022Variation
at current
exchange rates		Variation
at constant
exchange rates
Non-proprietary homeopathic medicines 126,771 129,957 -2.5% -2.1%
Homeopathic specialties 208,679 196,265 +6.3% +8.2%
Other health products 25,545 58,961 -56.7% -56.5%
Group total360,994385,183-6.3%-5.2%

Total sales fell 6.3%, impacted by a challenging basis for comparison following significant COVID test sales in France in 2022. Excluding these tests, sales were up 3%.

This growth was achieved in all regions and was driven by sales of homeopathic specialties.

Outlook

The decline in COVID test sales is expected to result in lower revenues in 2023 than in 2022. Excluding test sales, revenues are expected to grow, depending on winter illnesses at the end of the year.

We continue to put all our energy and determination into ensuring that every patient in the world can take advantage of homeopathy and our others healthcare solutions, thereby supporting a more humane, efficient and sustainable healthcare system.

Laboratoires BOIRON

Our next update:January 25, 2024: at market close, publication of the sales for the year 2023.
Person responsible for financial information: Valérie Lorentz-Poinsot
Contact for financial information: Fabrice Rey
Investor relations: +33 (0) 4.37.41.84.01 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information and the glossary are online at: www.boironfinance.com


This publication embed "🔒 Actusnews SECURITY MASTER".
- SECURITY MASTER Key: yJlrY8ltZmudnpyaaZdsnJaXam1qx2WXZ2bGk2SZaMubnJ1nl2qWZsaVZnFjmWts
- Check this key: https://www.security-master-key.com.

Regulated information:
Quarterly financial reporting:
- Third quarter financial report

Full and original press release in PDF: https://www.actusnews.com/news/82466-boi-201023-ca-t3-23-gb.pdf

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free


© 2023 ActusNews